Declining COGS and Admin Costs, combined with Increasing Revenues!!! Once Provenge is selling in Europe in the 4th Qtr this year, the stock will rocket up again. Take your positions now while the share price is a steal!!!!!! Profitability on the way as well!!!
These analysts act like this company is a start up biotech company...lol Its comical. We have an approved drug in the USA and in EUROPE!!!!!!!! Stock should be $15-25
Shorties are in pain....
DNDN - Check this one out guys...Also just bought 100 TSLA shares pre market!!